nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Daniel Porte Jr, 13 August 1931–13 May 2023
|
Kahn, Steven E. |
|
|
66 |
10 |
p. 1759-1761 |
artikel |
2 |
Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children’s cohort
|
Mehlig, Kirsten |
|
|
66 |
10 |
p. 1914-1924 |
artikel |
3 |
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
|
Kosjerina, Vanja |
|
|
66 |
10 |
p. 1908-1913 |
artikel |
4 |
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
|
Tschöp, Matthias |
|
|
66 |
10 |
p. 1796-1808 |
artikel |
5 |
Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production
|
Riahi, Yael |
|
|
66 |
10 |
p. 1925-1942 |
artikel |
6 |
Incretin hormones and type 2 diabetes
|
Nauck, Michael A. |
|
|
66 |
10 |
p. 1780-1795 |
artikel |
7 |
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
|
Solini, Anna |
|
|
66 |
10 |
p. 1820-1831 |
artikel |
8 |
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
|
Goldney, Jonathan |
|
|
66 |
10 |
p. 1832-1845 |
artikel |
9 |
Incretins beyond type 2 diabetes
|
Mathieu, Chantal |
|
|
66 |
10 |
p. 1809-1819 |
artikel |
10 |
Incretins: turning the venom into the antidote
|
Krook, Anna |
|
|
66 |
10 |
p. 1762-1764 |
artikel |
11 |
Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial
|
Garrib, Anupam |
|
|
66 |
10 |
p. 1882-1896 |
artikel |
12 |
Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells
|
Shah, Ruchi |
|
|
66 |
10 |
p. 1943-1958 |
artikel |
13 |
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
|
Anson, Matthew |
|
|
66 |
10 |
p. 1869-1881 |
artikel |
14 |
Socioeconomic aspects of incretin-based therapy
|
Karagiannis, Thomas |
|
|
66 |
10 |
p. 1859-1868 |
artikel |
15 |
Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial
|
Kobayashi, Yukari |
|
|
66 |
10 |
p. 1897-1907 |
artikel |
16 |
The expanding incretin universe: from basic biology to clinical translation
|
Drucker, Daniel J. |
|
|
66 |
10 |
p. 1765-1779 |
artikel |
17 |
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
|
Andreasen, Christine R. |
|
|
66 |
10 |
p. 1846-1858 |
artikel |
18 |
Up Front
|
|
|
|
66 |
10 |
p. 1757-1758 |
artikel |